Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 4, 2018

Primary Completion Date

July 27, 2018

Study Completion Date

August 13, 2018

Conditions
Nicotine Dependence, Other Tobacco ProductTobacco UseSmoking, Tobacco
Interventions
OTHER

Treatment with JUUL 5%, Virginia Tobacco

JUUL 5%, ENDS for 5-days in confinement

OTHER

Treatment with JUUL 5%, Cool Mint, ENDS

JUUL 5%, ENDS for 5-days in confinement

OTHER

Treatment with JUUL 5%, Mango, ENDS

JUUL 5%, ENDS for 5-days in confinement

OTHER

JUUL 5%, Creme Bruele, ENDS

JUUL 5%, ENDS for 5-days in confinement

OTHER

Combustible cigarette

Exclusive use of combustible cigarette for 5 days in confinement.

OTHER

Smoking Cessation

No smoking for 5-days in confinement.

Trial Locations (1)

68516

Celerion, Lincoln

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Juul Labs, Inc.

INDUSTRY

NCT03463837 - Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers | Biotech Hunter | Biotech Hunter